Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
Katsuyuki Sakanaka, Satoshi Itasaka, Yuichi Ishida, Kota Fujii, Takahiro Horimatsu, Takashi Mizowaki, Yoshiharu Sakai, Masahiro Hiraoka
Radiat Oncol J. 2017;35(4):368-379.   Published online 2017 Sep 15     DOI: https://doi.org/10.3857/roj.2017.00227
Citations to this article as recorded by Crossref logo
Anal squamous cell carcinoma – State of the art management and future perspectives
Daniel Martin, Panagiotis Balermpas, Ria Winkelmann, Franz Rödel, Claus Rödel, Emmanouil Fokas
Cancer Treatment Reviews.2018; 65: 11.     CrossRef
Cancer du canal anal : à l’ère de la radiothérapie conformationnelle avec modulation d’intensité, questions en suspens
D. Peiffert, A.S. Baumann, A.A. Serre, V. Vendrely, N. Rouard, J.C. Faivre, G. Vogin
Cancer/Radiothérapie.2018; 22(6-7): 509.     CrossRef
Assessment of the modulation degrees of intensity-modulated radiation therapy plans
So-Yeon Park, Jung-in Kim, Minsoo Chun, Hyunjun Ahn, Jong Min Park
Radiation Oncology.2018;[Epub]     CrossRef